GRIN1 (glutamate ionotropic receptor NMDA type subunit 1) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: GRIN1 (glutamate ionotropic receptor NMDA type subunit 1) Homo sapiens
Analyze
Symbol: GRIN1
Name: glutamate ionotropic receptor NMDA type subunit 1
RGD ID: 731784
HGNC Page HGNC:4584
Description: Enables carboxylic acid binding activity and ligand-gated monoatomic cation channel activity. Contributes to NMDA glutamate receptor activity and calcium channel activity. Involved in several processes, including ionotropic glutamate receptor signaling pathway; monoatomic cation transmembrane transport; and response to glycine. Located in dendrite and plasma membrane. Part of NMDA selective glutamate receptor complex. Implicated in alcohol use disorder; autosomal dominant intellectual developmental disorder 8; cerebral infarction; and developmental and epileptic encephalopathy 101. Biomarker of Alzheimer's disease; opioid abuse; and vascular dementia.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: DEE101; GluN1; glutamate [NMDA] receptor subunit zeta 1; glutamate [NMDA] receptor subunit zeta-1; glutamate receptor ionotropic, NMDA 1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; hNR1; MRD8; N-methyl-D-aspartate receptor channel, subunit zeta-1; N-methyl-D-aspartate receptor subunit NR1; NDHMSD; NDHMSR; NMD-R1; NMDA1; NMDAR1; NR1; putative NMDtranscript(altAcc_e2)
RGD Orthologs
Mouse
Rat
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Orthologs
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh389137,139,154 - 137,168,756 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl9137,138,346 - 137,168,756 (+)EnsemblGRCh38hg38GRCh38
GRCh379140,033,606 - 140,063,208 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 369139,153,430 - 139,183,029 (+)NCBINCBI36Build 36hg18NCBI36
Build 349137,308,678 - 137,339,043NCBI
Celera9110,548,072 - 110,577,040 (+)NCBICelera
Cytogenetic Map9q34.3NCBI
HuRef9109,493,914 - 109,523,231 (+)NCBIHuRef
CHM1_19140,182,355 - 140,211,903 (+)NCBICHM1_1
T2T-CHM13v2.09149,377,044 - 149,406,436 (+)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View
Adams-Oliver Syndrome 5  (IAGP)
alcohol use disorder  (IAGP)
Alzheimer's disease  (IEP)
Animal Disease Models  (EXP)
autism spectrum disorder  (IAGP,ISS)
autistic disorder  (IAGP)
autosomal dominant intellectual developmental disorder 8  (IAGP)
autosomal dominant nocturnal frontal lobe epilepsy 5  (IAGP)
benign epilepsy with centrotemporal spikes  (IAGP)
Brain Hypoxia-Ischemia  (ISO)
cerebral infarction  (IDA)
Cocaine-Related Disorders  (EXP)
cognitive disorder  (ISO)
developmental and epileptic encephalopathy 1  (IAGP)
developmental and epileptic encephalopathy 101  (IAGP)
developmental and epileptic encephalopathy 14  (IAGP)
Developmental Disabilities  (IAGP)
epilepsy  (IAGP)
Experimental Diabetes Mellitus  (ISO)
Febrile Seizures  (IAGP)
genetic disease  (IAGP)
Hemimegalencephaly  (IAGP)
Hyperalgesia  (EXP)
intellectual disability  (IAGP)
Joubert syndrome 1  (IAGP)
Kleefstra syndrome 1  (IAGP)
Language Development Disorders  (IAGP)
Leigh disease  (IAGP)
Macrocephaly  (IAGP)
middle cerebral artery infarction  (ISO)
morphine dependence  (ISO)
Neurodevelopmental Disorder with or without Hyperkinetic Movements and Seizures, Autosomal Recessive  (IAGP)
Neurodevelopmental Disorders  (IAGP)
opioid abuse  (IEP)
Pain  (EXP)
placental insufficiency  (ISO)
primary coenzyme Q10 deficiency 7  (IAGP)
prostate cancer  (IAGP)
psychotic disorder  (EXP)
Rafiq syndrome  (IAGP)
schizophrenia  (ISS)
sciatic neuropathy  (ISO)
status epilepticus  (ISO)
trigeminal neuralgia  (EXP)
tuberous sclerosis 1  (IAGP)
vascular dementia  (IEP)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-pilocarpine  (ISO)
(25R)-cholest-5-ene-3beta,26-diol  (ISO)
(R)-lipoic acid  (ISO)
(S)-3,5-dihydroxyphenylglycine  (ISO)
(S)-colchicine  (EXP)
1,2-dichloroethane  (ISO)
1,2-dimethylhydrazine  (ISO)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine  (ISO)
1-naphthyl isothiocyanate  (ISO)
17beta-estradiol  (EXP,ISO)
17beta-estradiol 3-benzoate  (ISO)
2,2',4,4'-Tetrabromodiphenyl ether  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (ISO)
2,3,7,8-Tetrachlorodibenzofuran  (ISO)
2,6-dinitrotoluene  (ISO)
2-methyl-6-(phenylethynyl)pyridine  (ISO)
2-methylcholine  (EXP)
26-hydroxycholesterol  (ISO)
3',5'-cyclic AMP  (EXP)
3,4-methylenedioxymethamphetamine  (ISO)
3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione  (ISO)
4,4'-sulfonyldiphenol  (EXP,ISO)
4-[1-hydroxy-2-[4-(phenylmethyl)-1-piperidinyl]propyl]phenol  (ISO)
6-propyl-2-thiouracil  (ISO)
acetamiprid  (ISO)
acrylamide  (EXP,ISO)
aflatoxin B1  (EXP)
Aflatoxin B2 alpha  (EXP)
agmatine  (ISO)
agomelatine  (ISO)
aldehydo-D-glucose  (ISO)
all-trans-retinoic acid  (EXP)
alpha-amanitin  (ISO)
alpha-D-galactose  (ISO)
alpha-Zearalanol  (ISO)
ammonium chloride  (ISO)
amphetamine  (ISO)
androgen antagonist  (ISO)
aristolochic acid A  (EXP)
arsane  (EXP)
arsenic atom  (EXP)
arsenite(3-)  (EXP,ISO)
arsenous acid  (ISO)
astaxanthin  (ISO)
atrazine  (ISO)
benzo[a]pyrene  (EXP,ISO)
bis(2-ethylhexyl) phthalate  (ISO)
bisphenol A  (EXP,ISO)
Butylparaben  (ISO)
C60 fullerene  (ISO)
cadmium dichloride  (ISO)
caffeine  (ISO)
capsaicin  (ISO)
celecoxib  (ISO)
chlorpyrifos  (ISO)
choline  (ISO)
clozapine  (ISO)
cocaine  (EXP,ISO)
colforsin daropate hydrochloride  (ISO)
copper atom  (ISO)
copper(0)  (ISO)
curcumin  (ISO)
cyclosporin A  (EXP)
cyhalothrin  (ISO)
cypermethrin  (EXP)
D-aspartic acid  (ISO)
D-glucose  (ISO)
DDE  (ISO)
decabromodiphenyl ether  (ISO)
dexamethasone  (ISO)
dextromethorphan  (ISO)
diarsenic trioxide  (ISO)
diazinon  (ISO)
dibutyl phthalate  (ISO)
dieldrin  (ISO)
dizocilpine maleate  (EXP,ISO)
dopamine  (ISO)
endosulfan  (ISO)
enzacamene  (ISO)
epoxiconazole  (ISO)
ethanol  (ISO)
excitatory amino acid agonist  (EXP,ISO)
felbamate  (ISO)
fenvalerate  (EXP,ISO)
Fluorocitric acid  (ISO)
folic acid  (ISO)
fucoxanthin  (ISO)
fulvestrant  (ISO)
fumonisin B1  (EXP)
gabapentin  (EXP)
galactose  (ISO)
gamma-tocopherol  (ISO)
genistein  (EXP)
gentamycin  (ISO)
glucose  (ISO)
glyphosate  (EXP,ISO)
haloperidol  (ISO)
herbicide  (ISO)
homocysteine  (ISO)
hydroxyurea  (EXP)
imipramine  (EXP)
kainic acid  (ISO)
ketamine  (ISO)
KT 5720  (ISO)
L-ascorbic acid  (EXP)
L-methionine  (ISO)
lanthanum trichloride  (ISO)
lead diacetate  (ISO)
lead(0)  (EXP,ISO)
lead(II) chloride  (ISO)
linuron  (ISO)
lipoic acid  (ISO)
lipoteichoic acid  (ISO)
lithium chloride  (EXP,ISO)
manganese atom  (ISO)
manganese(0)  (ISO)
manganese(II) chloride  (ISO)
melamine  (ISO)
melatonin  (ISO)
methamphetamine  (ISO)
methapyrilene  (EXP)
methoxychlor  (ISO)
methylmercury chloride  (ISO)
monosodium L-glutamate  (ISO)
morphine  (ISO)
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide  (ISO)
nobiletin  (ISO)
Nonylphenol  (ISO)
Nor-9-carboxy-delta9-THC  (EXP)
notoginsenoside R1  (EXP)
ochratoxin A  (EXP)
oxidopamine  (ISO)
oxybenzone  (ISO)
ozone  (ISO)
paracetamol  (ISO)
paraquat  (ISO)
parathion  (ISO)
PCB138  (ISO)
pentobarbital  (ISO)
perfluorooctane-1-sulfonic acid  (ISO)
perfluorooctanoic acid  (ISO)
phencyclidine  (ISO)
phenytoin  (ISO)
picloram  (ISO)
prochloraz  (ISO)
procymidone  (ISO)
resveratrol  (ISO)
semicarbazide  (EXP)
SKF 38393  (ISO)
sodium arsenite  (ISO)
streptozocin  (ISO)
sulfadiazine  (EXP)
sulfur dioxide  (ISO)
sulindac  (ISO)
testosterone  (EXP)
thimerosal  (ISO)
titanium dioxide  (ISO)
tocopherol  (ISO)
toluene  (ISO)
tributylstannane  (ISO)
trichlopyr  (ISO)
triphenyl phosphate  (ISO)
triptonide  (ISO)
urethane  (EXP)
valproic acid  (ISO)
vinclozolin  (ISO)
WIN 55212-2  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
adult locomotory behavior  (ISO)
associative learning  (ISO)
brain development  (NAS)
calcium ion homeostasis  (ISO,ISS)
calcium ion transmembrane import into cytosol  (IDA)
calcium ion transmembrane transport  (IDA)
calcium ion transport  (ISO)
calcium-mediated signaling  (IEA)
cellular response to amyloid-beta  (IGI)
cellular response to glycine  (ISO)
cellular response to manganese ion  (ISO)
cerebral cortex development  (ISO)
chemical synaptic transmission  (IBA)
conditioned taste aversion  (ISO)
excitatory chemical synaptic transmission  (NAS)
excitatory postsynaptic potential  (ISO,ISS)
intracellular calcium ion homeostasis  (ISO)
ionotropic glutamate receptor signaling pathway  (IBA,IEA,IMP,ISO,ISS,NAS)
learning  (ISO)
learning or memory  (ISO)
long-term memory  (ISO)
male mating behavior  (ISO)
memory  (ISO)
monoatomic cation transmembrane transport  (IDA,ISO,ISS,NAS)
monoatomic cation transport  (IDA,ISO)
monoatomic ion transmembrane transport  (IEA)
monoatomic ion transport  (IEA)
negative regulation of neuron apoptotic process  (ISO)
neuromuscular process  (ISO)
neuron cellular homeostasis  (ISO)
olfactory learning  (ISO)
pons maturation  (ISO)
positive regulation of apoptotic process  (ISO)
positive regulation of calcium ion transport into cytosol  (ISS)
positive regulation of dendritic spine maintenance  (ISO)
positive regulation of excitatory postsynaptic potential  (ISO,ISS,NAS)
positive regulation of reactive oxygen species biosynthetic process  (ISS)
positive regulation of Schwann cell migration  (ISO)
positive regulation of synaptic transmission, glutamatergic  (ISO,ISS,NAS)
positive regulation of transcription by RNA polymerase II  (ISO,ISS)
prepulse inhibition  (ISO)
propylene metabolic process  (ISS)
protein heterotetramerization  (ISS)
protein localization to postsynaptic membrane  (ISO)
protein-containing complex assembly  (ISO)
regulation of axonogenesis  (ISO)
regulation of cell communication  (ISO)
regulation of dendrite morphogenesis  (ISO)
regulation of long-term neuronal synaptic plasticity  (ISO)
regulation of membrane potential  (IBA,IDA,ISO)
regulation of monoatomic cation transmembrane transport  (ISO,ISS,NAS)
regulation of neuron apoptotic process  (ISO)
regulation of neuronal synaptic plasticity  (ISO,NAS)
regulation of respiratory gaseous exchange  (ISO)
regulation of synapse assembly  (ISO)
regulation of synaptic plasticity  (ISO,ISS,NAS)
response to amine  (ISO)
response to amphetamine  (ISO)
response to calcium ion  (ISO)
response to ethanol  (IDA)
response to fungicide  (ISO)
response to glycine  (IDA)
response to glycoside  (ISO)
response to hypoxia  (ISO)
response to morphine  (ISO)
rhythmic process  (ISO)
sensory perception of pain  (ISO)
social behavior  (ISO)
sodium ion transmembrane transport  (IDA)
startle response  (ISO)
suckling behavior  (ISO)
synaptic transmission, glutamatergic  (ISO)
transcription by RNA polymerase II  (ISO)
visual learning  (ISO,ISS)

Molecular Pathway Annotations     Click to see Annotation Detail View
alfentanil pharmacodynamics pathway   (EXP)
Alzheimer's disease pathway  (IEA)
amyotrophic lateral sclerosis pathway  (IEA)
bupivacaine pharmacodynamics pathway  (EXP)
buprenorphine pharmacodynamics pathway   (EXP)
calcium/calmodulin dependent kinase 2 signaling pathway  (TAS)
chloroprocaine pharmacodynamics pathway  (EXP)
citalopram pharmacodynamics pathway  (EXP)
cocaine pharmacodynamics pathway  (EXP)
codeine and morphine pharmacodynamics pathway  (EXP)
desipramine pharmacodynamics pathway  (EXP)
diphenoxylate pharmacodynamics pathway  (EXP)
escitalopram pharmacodynamics pathway  (EXP)
ethylmorphine pharmacodynamics pathway  (EXP)
excitatory synaptic transmission pathway  (ISO)
fentanyl pharmacodynamics pathway  (EXP)
fluoxetine pharmacodynamics pathway  (EXP)
glutamate signaling pathway  (IEA)
heroin pharmacodynamics pathway   (EXP)
Huntington's disease pathway  (IEA)
hydrocodone pharmacodynamics pathway  (EXP)
hydromorphone pharmacodynamics pathway  (EXP)
imipramine pharmacodynamics pathway  (EXP)
levacetylmethadol pharmacodynamics pathway  (EXP)
levobupivacaine phgarmacodynamics pathway  (EXP)
levorphanol pharmacodynamics pathway  (EXP)
lidocaine pharmacodynamics pathway  (EXP)
long term potentiation  (IEA)
mepivacaine pharmacodynamics pathway  (EXP)
methadone pharmacodynamics pathway  (EXP)
methadone pharmacokinetics pathway  (EXP)
nalbuphine pharmacodynamics pathway  (EXP)
naloxone pharmacodynamics pathway  (EXP)
naltrexone pharmacodynamics pathway  (EXP)
nicotine pharmacodynamics pathway  (EXP)
oxybuprocaine pharmacodynamics pathway  (EXP)
oxycodone pharmacodynamics pathway  (EXP)
oxymorphone pharmacodynamics pathway  (EXP)
pentazocine pharmacodynamics pathway  (EXP)
prilocaine pharmacodynamics pathway  (EXP)
procaine pharmacodynamics pathway  (EXP)
remifentanil pharmacodynamics pathway  (EXP)
ropivacaine pharmacodynamics pathway  (EXP)
tramadol pharmacodynamics pathway  (EXP)

Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
Abnormal hippocampus morphology  (IAGP)
Abnormality of movement  (IAGP)
Absent speech  (IAGP)
Absent thumbnail  (IAGP)
Anteverted nares  (IAGP)
Apnea  (IAGP)
Atonic seizure  (IAGP)
Atypical behavior  (IAGP)
Autism  (IAGP)
Autistic behavior  (IAGP)
Autosomal dominant inheritance  (IAGP)
Autosomal recessive inheritance  (IAGP)
Axial hypotonia  (IAGP)
Bilateral tonic-clonic seizure  (IAGP)
Bradycardia  (IAGP)
Broad finger  (IAGP)
Broad phalanx of the toes  (IAGP)
Bruxism  (IAGP)
Cerebellar atrophy  (IAGP)
Cerebral atrophy  (IAGP)
Cerebral cortical atrophy  (IAGP)
Cerebral visual impairment  (IAGP)
Chorea  (IAGP)
Choreoathetosis  (IAGP)
Cleft palate  (IAGP)
Congenital onset  (IAGP)
Constipation  (IAGP)
Deeply set eye  (IAGP)
Delayed ability to sit  (IAGP)
Delayed ability to walk  (IAGP)
Delayed gross motor development  (IAGP)
Delayed myelination  (IAGP)
Depressed nasal bridge  (IAGP)
Developmental regression  (IAGP)
Diffuse cerebral atrophy  (IAGP)
Diffuse white matter abnormalities  (IAGP)
Dyskinesia  (IAGP)
Dysphagia  (IAGP)
Dystonia  (IAGP)
EEG abnormality  (IAGP)
EEG with burst suppression  (IAGP)
EEG with spike-wave complexes  (IAGP)
Epileptic encephalopathy  (IAGP)
Epileptic spasm  (IAGP)
Episodic ataxia  (IAGP)
Expressive language delay  (IAGP)
Eyelid myoclonus  (IAGP)
Failure to thrive  (IAGP)
Febrile seizure (within the age range of 3 months to 6 years)  (IAGP)
Feeding difficulties  (IAGP)
Focal emotional seizure with laughing  (IAGP)
Focal impaired awareness seizure  (IAGP)
Focal motor seizure  (IAGP)
Focal tonic seizure  (IAGP)
Focal-onset seizure  (IAGP)
Frontal bossing  (IAGP)
Gastroesophageal reflux  (IAGP)
Generalized clonic seizure  (IAGP)
Generalized myoclonic seizure  (IAGP)
Generalized non-motor (absence) seizure  (IAGP)
Generalized tonic seizure  (IAGP)
Generalized-onset seizure  (IAGP)
Global developmental delay  (IAGP)
Growth delay  (IAGP)
Hemimegalencephaly  (IAGP)
Hyperactivity  (IAGP)
Hyperkinetic movements  (IAGP)
Hyperreflexia  (IAGP)
Hypoplasia of the corpus callosum  (IAGP)
Hypoplastic hippocampus  (IAGP)
Hypotonia  (IAGP)
Hypsarrhythmia  (IAGP)
Impaired mastication  (IAGP)
Inability to walk  (IAGP)
Inappropriate laughter  (IAGP)
Infantile muscular hypotonia  (IAGP)
Infantile onset  (IAGP)
Infantile spasms  (IAGP)
Intellectual disability  (IAGP)
Intellectual disability, mild  (IAGP)
Intellectual disability, moderate  (IAGP)
Intellectual disability, profound  (IAGP)
Intellectual disability, severe  (IAGP)
Involuntary movements  (IAGP)
Lateral ventricle dilatation  (IAGP)
Lethargy  (IAGP)
Limb joint contracture  (IAGP)
Long face  (IAGP)
Macrocephaly  (IAGP)
Microcephaly  (IAGP)
Micropenis  (IAGP)
Midface retrusion  (IAGP)
Motor stereotypy  (IAGP)
Mutism  (IAGP)
Myoclonic seizure  (IAGP)
Myoclonus  (IAGP)
Nasogastric tube feeding  (IAGP)
Neonatal onset  (IAGP)
Neurodevelopmental delay  (IAGP)
Obstructive sleep apnea  (IAGP)
Oculogyric crisis  (IAGP)
Opisthotonus  (IAGP)
Oral-pharyngeal dysphagia  (IAGP)
Pachygyria  (IAGP)
Paroxysmal dyskinesia  (IAGP)
Polymicrogyria  (IAGP)
Poor head control  (IAGP)
Poor suck  (IAGP)
Precocious puberty  (IAGP)
Profound global developmental delay  (IAGP)
Prostate cancer  (IAGP)
Recurrent respiratory infections  (IAGP)
Reduced eye contact  (IAGP)
Reduced social responsiveness  (IAGP)
Renal dysplasia  (IAGP)
Scoliosis  (IAGP)
Seizure  (IAGP)
Self-injurious behavior  (IAGP)
Severe global developmental delay  (IAGP)
Severe muscular hypotonia  (IAGP)
Short finger  (IAGP)
Short stature  (IAGP)
Single transverse palmar crease  (IAGP)
Sleep abnormality  (IAGP)
Sloping forehead  (IAGP)
Spastic tetraplegia  (IAGP)
Spasticity  (IAGP)
Status epilepticus  (IAGP)
Stereotypical hand wringing  (IAGP)
Strabismus  (IAGP)
Third degree atrioventricular block  (IAGP)
Total ophthalmoplegia  (IAGP)
Tremor  (IAGP)
Typical absence seizure  (IAGP)
Umbilical hernia  (IAGP)
Uni- and bilateral multifocal epileptiform discharges  (IAGP)
Ureterocele  (IAGP)
Ventricular septal defect  (IAGP)
Ventriculomegaly  (IAGP)
Widened subarachnoid space  (IAGP)
References

References - curated
# Reference Title Reference Citation
1. CaMKII regulation in information processing and storage. Coultrap SJ and Bayer KU, Trends Neurosci. 2012 Oct;35(10):607-18. doi: 10.1016/j.tins.2012.05.003. Epub 2012 Jun 19.
2. NMDA receptor subunits change in the prefrontal cortex of pure-opioid and multi-drug abusers: a post-mortem study. Daneshparvar H, etal., Eur Arch Psychiatry Clin Neurosci. 2019 Apr;269(3):309-315. doi: 10.1007/s00406-018-0900-8. Epub 2018 May 16.
3. Early modifications in N-methyl-D-aspartate receptor subunit mRNA levels in an oxygen and glucose deprivation model using rat hippocampal brain slices. Dos-Anjos S, etal., Neuroscience. 2009 Dec 15;164(3):1119-26. Epub 2009 Sep 15.
4. GOAs Human GO annotations GOA_HUMAN data from the GO Consortium
5. Prenatal development of NMDA receptor composition and function in trigeminal neurons. Ishihama K, etal., Arch Histol Cytol. 2005 Dec;68(4):321-35.
6. CaMKII-dependent dendrite ramification and spine generation promote spatial training-induced memory improvement in a rat model of sporadic Alzheimer's disease. Jiang X, etal., Neurobiol Aging. 2015 Feb;36(2):867-76. doi: 10.1016/j.neurobiolaging.2014.10.018. Epub 2014 Oct 16.
7. Stroke patients develop antibodies that react with components of N-methyl-D-aspartate receptor subunit 1 in proportion to lesion size. Kalev-Zylinska ML, etal., Stroke. 2013 Aug;44(8):2212-9. doi: 10.1161/STROKEAHA.113.001235. Epub 2013 May 30.
8. Pathological reorganization of NMDA receptors subunits and postsynaptic protein PSD-95 distribution in Alzheimer's disease. Leuba G, etal., Curr Alzheimer Res. 2014 Jan;11(1):86-96.
9. Long Noncoding RNA FosDT Promotes Ischemic Brain Injury by Interacting with REST-Associated Chromatin-Modifying Proteins. Mehta SL, etal., J Neurosci. 2015 Dec 16;35(50):16443-9. doi: 10.1523/JNEUROSCI.2943-15.2015.
10. Differential alterations of neocortical GluN receptor subunits in patients with mixed subcortical ischemic vascular dementia and Alzheimer's disease. Mohamed NE, etal., J Alzheimers Dis. 2015;44(2):431-7. doi: 10.3233/JAD-141764.
11. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Monyer H, etal., Science 1992 May 22;256(5060):1217-21.
12. Morphine Dependence is Attenuated by Treatment of 3,4,5-Trimethoxy Cinnamic Acid in Mice and Rats. Moon S, etal., Neurochem Res. 2019 Apr;44(4):874-883. doi: 10.1007/s11064-019-02720-9. Epub 2019 Jan 10.
13. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
14. Online Mendelian Inheritance in Man, OMIM (TM). Online Mendelian Inheritance in Man, OMIM (TM).
15. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
16. SMPDB Annotation Import Pipeline Pipeline to import SMPDB annotations from SMPDB into RGD
17. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
18. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
19. RGD HPO Phenotype Annotation Pipeline RGD automated import pipeline for human HPO-to-gene-to-disease annotations
20. Intrauterine growth restriction due to uteroplacental insufficiency decreased white matter and altered NMDAR subunit composition in juvenile rat hippocampi. Schober ME, etal., Am J Physiol Regul Integr Comp Physiol. 2009 Mar;296(3):R681-92. Epub 2009 Jan 14.
21. Object-based analysis of astroglial reaction and astrocyte subtype morphology after ischemic brain injury. Wagner DC, etal., Acta Neurobiol Exp (Wars). 2013;73(1):79-87.
22. Hippocampal NMDAR-Wnt-Catenin signaling disrupted with cognitive deficits in adolescent offspring exposed to prenatal hypoxia. Wei B, etal., Brain Res. 2016 Jan 15;1631:157-64. doi: 10.1016/j.brainres.2015.11.041. Epub 2015 Dec 2.
23. Polymorphisms in the N-methyl-D-aspartate receptor 1 and 2B subunits are associated with alcoholism-related traits. Wernicke C, etal., Biol Psychiatry. 2003 Nov 1;54(9):922-8.
Additional References at PubMed
PMID:7622053   PMID:7679115   PMID:7681588   PMID:7685113   PMID:7695237   PMID:7926821   PMID:8139656   PMID:8316301   PMID:8406025   PMID:8406459   PMID:8563977   PMID:8581564  
PMID:8615909   PMID:8625412   PMID:8665664   PMID:8724036   PMID:8768735   PMID:8783260   PMID:8804048   PMID:8821747   PMID:8822372   PMID:8845955   PMID:8889548   PMID:8955056  
PMID:9009191   PMID:9030583   PMID:9231706   PMID:9425014   PMID:9481670   PMID:9482789   PMID:9489750   PMID:9502803   PMID:9620802   PMID:9651389   PMID:9670010   PMID:9694809  
PMID:9721050   PMID:9728925   PMID:9745929   PMID:9835392   PMID:9952395   PMID:10049997   PMID:10197777   PMID:10373510   PMID:10448428   PMID:10480938   PMID:10518580   PMID:10555109  
PMID:10749211   PMID:10862698   PMID:11109007   PMID:11136979   PMID:11140673   PMID:11140838   PMID:11160393   PMID:11279200   PMID:11483648   PMID:11506858   PMID:11588171   PMID:11606043  
PMID:11754835   PMID:11803122   PMID:11897110   PMID:11937501   PMID:12008020   PMID:12068077   PMID:12082569   PMID:12191494   PMID:12210277   PMID:12363394   PMID:12391275   PMID:12408866  
PMID:12414113   PMID:12610658   PMID:12646920   PMID:12679240   PMID:12707933   PMID:12746393   PMID:12753088   PMID:12775422   PMID:12815021   PMID:12893641   PMID:14529713   PMID:14575242  
PMID:14602821   PMID:14622581   PMID:14644469   PMID:14732708   PMID:14970236   PMID:14973229   PMID:15003177   PMID:15030408   PMID:15030493   PMID:15069201   PMID:15255944   PMID:15265015  
PMID:15317856   PMID:15338240   PMID:15448144   PMID:15531111   PMID:15564900   PMID:15635650   PMID:15721239   PMID:15749123   PMID:15841096   PMID:15888440   PMID:16140270   PMID:16157279  
PMID:16189506   PMID:16272960   PMID:16289038   PMID:16332682   PMID:16476413   PMID:16481105   PMID:16489129   PMID:16510730   PMID:16697675   PMID:16767099   PMID:16969270   PMID:17047094  
PMID:17255096   PMID:17284422   PMID:17360663   PMID:17459877   PMID:17506933   PMID:17526495   PMID:17728671   PMID:17997397   PMID:18068304   PMID:18182392   PMID:18233995   PMID:18296432  
PMID:18445116   PMID:18606955   PMID:18644839   PMID:18792810   PMID:18990687   PMID:18991843   PMID:19020013   PMID:19036954   PMID:19095845   PMID:19156168   PMID:19328558   PMID:19422642  
PMID:19487695   PMID:19488045   PMID:19526283   PMID:19556342   PMID:19602553   PMID:19635471   PMID:19784770   PMID:19811606   PMID:19874574   PMID:20007519   PMID:20097831   PMID:20237496  
PMID:20414717   PMID:20438806   PMID:20468064   PMID:20634195   PMID:20722663   PMID:20848605   PMID:20974228   PMID:21376300   PMID:21491143   PMID:21670103   PMID:21753020   PMID:21873635  
PMID:21883149   PMID:21948112   PMID:22040728   PMID:22114277   PMID:22196339   PMID:22300668   PMID:22354721   PMID:22375001   PMID:22383529   PMID:22448134   PMID:22486492   PMID:22544902  
PMID:22552781   PMID:22711533   PMID:22726567   PMID:22833210   PMID:22889411   PMID:22937865   PMID:22940423   PMID:22952988   PMID:23070074   PMID:23267846   PMID:23271275   PMID:23604598  
PMID:23621516   PMID:23665428   PMID:23726511   PMID:23840674   PMID:23864692   PMID:23880023   PMID:23933820   PMID:23999527   PMID:24086760   PMID:24227730   PMID:24272827   PMID:24292102  
PMID:24655651   PMID:24739951   PMID:25017909   PMID:25232120   PMID:25431428   PMID:25613138   PMID:25683482   PMID:25760043   PMID:25864721   PMID:26013316   PMID:26253177   PMID:26584860  
PMID:26819771   PMID:26875626   PMID:26919761   PMID:27164704   PMID:27443784   PMID:27596138   PMID:27831563   PMID:28051072   PMID:28095420   PMID:28105280   PMID:28126851   PMID:28228639  
PMID:28244984   PMID:28262924   PMID:28298427   PMID:28378791   PMID:28389307   PMID:28702665   PMID:29057721   PMID:29194067   PMID:29339073   PMID:29365063   PMID:29676528   PMID:29921713  
PMID:29987050   PMID:30200940   PMID:30214040   PMID:30482728   PMID:30590034   PMID:30704411   PMID:30776697   PMID:31025605   PMID:31219694   PMID:31429998   PMID:31444392   PMID:31512412  
PMID:31875540   PMID:32289863   PMID:32814053   PMID:33023061   PMID:33025395   PMID:33122756   PMID:33237434   PMID:33248694   PMID:33359543   PMID:33491170   PMID:33773999   PMID:33961781  
PMID:33969428   PMID:34100982   PMID:34227748   PMID:34321660   PMID:34592350   PMID:34666996   PMID:34689535   PMID:34726335   PMID:34781056   PMID:34840971   PMID:34884460   PMID:35393335  
PMID:36128677   PMID:36309015   PMID:36543183   PMID:36544563   PMID:36688959   PMID:36959261   PMID:37000222   PMID:37142655   PMID:37248111   PMID:37686003   PMID:37734923   PMID:38538865  
PMID:38598639   PMID:38836461  


Genomics

Comparative Map Data
GRIN1
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh389137,139,154 - 137,168,756 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl9137,138,346 - 137,168,756 (+)EnsemblGRCh38hg38GRCh38
GRCh379140,033,606 - 140,063,208 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 369139,153,430 - 139,183,029 (+)NCBINCBI36Build 36hg18NCBI36
Build 349137,308,678 - 137,339,043NCBI
Celera9110,548,072 - 110,577,040 (+)NCBICelera
Cytogenetic Map9q34.3NCBI
HuRef9109,493,914 - 109,523,231 (+)NCBIHuRef
CHM1_19140,182,355 - 140,211,903 (+)NCBICHM1_1
T2T-CHM13v2.09149,377,044 - 149,406,436 (+)NCBIT2T-CHM13v2.0
Grin1
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39225,181,189 - 25,209,199 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl225,181,193 - 25,209,199 (-)EnsemblGRCm39 Ensembl
GRCm38225,291,177 - 25,319,187 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl225,291,181 - 25,319,187 (-)EnsemblGRCm38mm10GRCm38
MGSCv37225,146,697 - 25,174,683 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36225,114,256 - 25,140,988 (-)NCBIMGSCv36mm8
Celera225,018,687 - 25,046,664 (-)NCBICelera
Cytogenetic Map2A3NCBI
cM Map217.14NCBI
Grin1
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr8328,501,836 - 28,528,754 (-)NCBIGRCr8
mRatBN7.238,103,680 - 8,130,603 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl38,103,680 - 8,130,603 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx311,208,200 - 11,235,127 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0319,794,430 - 19,821,357 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0317,984,273 - 18,011,200 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.032,507,745 - 2,534,664 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl32,506,896 - 2,534,663 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.032,489,158 - 2,516,082 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.433,453,784 - 3,480,381 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.133,453,783 - 3,480,381 (-)NCBI
Celera32,930,222 - 2,957,142 (-)NCBICelera
Cytogenetic Map3p13NCBI
Grin1
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_0049555135,154,864 - 5,178,636 (+)EnsemblChiLan1.0
ChiLan1.0NW_0049555135,154,864 - 5,178,636 (+)NCBIChiLan1.0ChiLan1.0
GRIN1
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v2112,230,366 - 2,260,063 (-)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan192,232,699 - 2,262,393 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v09108,198,350 - 108,228,887 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.19137,168,543 - 137,198,297 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl9137,168,722 - 137,197,382 (+)Ensemblpanpan1.1panPan2
GRIN1
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1948,492,967 - 48,513,981 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl948,493,287 - 48,509,050 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha947,683,789 - 47,707,011 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0949,357,798 - 49,382,176 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl949,357,798 - 49,383,084 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1948,135,045 - 48,158,254 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0948,433,856 - 48,457,059 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0948,481,015 - 48,504,246 (-)NCBIUU_Cfam_GSD_1.0
Grin1
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_024404947202,536,077 - 202,560,723 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_004936669814,330 - 839,208 (-)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_004936669814,330 - 838,881 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
GRIN1
(Sus scrofa - pig)
No map positions available.
GRIN1
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.1121,020,556 - 1,050,568 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl121,019,263 - 1,050,231 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_0236660584,254,719 - 4,284,702 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Grin1
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_004624760776,873 - 801,354 (-)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_004624760777,208 - 800,525 (-)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in GRIN1
957 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
NM_007327.4(GRIN1):c.2298C>T (p.Ser766=) single nucleotide variant Inborn genetic diseases [RCV002448770]|Intellectual disability, autosomal dominant 8 [RCV000530526] Chr9:137163295 [GRCh38]
Chr9:140057747 [GRCh37]
Chr9:9q34.3
likely benign
NM_007327.4(GRIN1):c.467G>A (p.Arg156His) single nucleotide variant Inborn genetic diseases [RCV002316577]|Intellectual disability, autosomal dominant 8 [RCV000550660]|not provided [RCV001561619] Chr9:137145799 [GRCh38]
Chr9:140040251 [GRCh37]
Chr9:9q34.3
likely benign|uncertain significance
NM_007327.4(GRIN1):c.1910C>T (p.Ala637Val) single nucleotide variant GRIN1-related disorder [RCV004537882]|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive [RCV001196588]|not provided [RCV000522670] Chr9:137162636 [GRCh38]
Chr9:140057088 [GRCh37]
Chr9:9q34.3
likely pathogenic|uncertain significance
NM_007327.4(GRIN1):c.1984G>A (p.Glu662Lys) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000022577] Chr9:137162710 [GRCh38]
Chr9:140057162 [GRCh37]
Chr9:9q34.3
pathogenic
NM_007327.4(GRIN1):c.1679_1681dup (p.Ser560dup) duplication Intellectual disability, autosomal dominant 8 [RCV000022578] Chr9:137162216..137162217 [GRCh38]
Chr9:140056668..140056669 [GRCh37]
Chr9:9q34.3
pathogenic
NC_000009.11:g.(?_139943109)_(140269288_?)dup duplication Intellectual disability, autosomal dominant 8 [RCV001996989] Chr9:139943109..140269288 [GRCh37]
Chr9:9q34.3
uncertain significance
NM_007327.4(GRIN1):c.1765T>C (p.Phe589Leu) single nucleotide variant not provided [RCV000727630] Chr9:137162417 [GRCh38]
Chr9:140056869 [GRCh37]
Chr9:9q34.3
uncertain significance
NM_007327.4(GRIN1):c.1858G>A (p.Gly620Arg) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000576875] Chr9:137162510 [GRCh38]
Chr9:140056962 [GRCh37]
Chr9:9q34.3
pathogenic|likely pathogenic
NM_007327.4(GRIN1):c.2449T>C (p.Phe817Leu) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000576887] Chr9:137163764 [GRCh38]
Chr9:140058216 [GRCh37]
Chr9:9q34.3
pathogenic
NM_007327.4(GRIN1):c.1930G>A (p.Val644Met) single nucleotide variant not provided [RCV000519384] Chr9:137162656 [GRCh38]
Chr9:140057108 [GRCh37]
Chr9:9q34.3
pathogenic
GRCh38/hg38 9q34.3(chr9:136323974-138014606)x1 copy number loss See cases [RCV000050344] Chr9:136323974..138014606 [GRCh38]
Chr9:139218428..140909058 [GRCh37]
Chr9:138338249..140028879 [NCBI36]
Chr9:9q34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 copy number gain See cases [RCV000050348] Chr9:193412..138179445 [GRCh38]
Chr9:204193..141073897 [GRCh37]
Chr9:194193..140193718 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9q33.2-34.3(chr9:122792658-138124532)x3 copy number gain See cases [RCV000051040] Chr9:122792658..138124532 [GRCh38]
Chr9:125554937..141018984 [GRCh37]
Chr9:124594758..140138805 [NCBI36]
Chr9:9q33.2-34.3
pathogenic
GRCh38/hg38 9q34.3(chr9:136323974-138124532)x1 copy number loss See cases [RCV000051116] Chr9:136323974..138124532 [GRCh38]
Chr9:139218428..141018984 [GRCh37]
Chr9:138338249..140138805 [NCBI36]
Chr9:9q34.3
pathogenic
GRCh38/hg38 9q33.2-34.3(chr9:121112395-138075224)x3 copy number gain See cases [RCV000051009] Chr9:121112395..138075224 [GRCh38]
Chr9:123874673..140969676 [GRCh37]
Chr9:122914494..140089497 [NCBI36]
Chr9:9q33.2-34.3
pathogenic
GRCh38/hg38 9q34.3(chr9:135452016-137613738)x1 copy number loss See cases [RCV000052937] Chr9:135452016..137613738 [GRCh38]
Chr9:138343862..140508190 [GRCh37]
Chr9:137483683..139628011 [NCBI36]
Chr9:9q34.3
pathogenic
GRCh38/hg38 9q34.3(chr9:137092629-137375788)x1 copy number loss See cases [RCV000052887] Chr9:137092629..137375788 [GRCh38]
Chr9:139987081..140270240 [GRCh37]
Chr9:139106902..139390061 [NCBI36]
Chr9:9q34.3
uncertain significance
GRCh38/hg38 9q34.2-34.3(chr9:134428674-138154922)x1 copy number loss See cases [RCV000052936] Chr9:134428674..138154922 [GRCh38]
Chr9:137320520..141049374 [GRCh37]
Chr9:136460341..140169195 [NCBI36]
Chr9:9q34.2-34.3
pathogenic
GRCh38/hg38 9q34.3(chr9:136015976-138124532)x1 copy number loss Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052938]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052938]|See cases [RCV000052938] Chr9:136015976..138124532 [GRCh38]
Chr9:138907822..141018984 [GRCh37]
Chr9:138047643..140138805 [NCBI36]
Chr9:9q34.3
pathogenic
GRCh38/hg38 9q34.3(chr9:136926575-138114463)x1 copy number loss See cases [RCV000052940] Chr9:136926575..138114463 [GRCh38]
Chr9:139821027..141008915 [GRCh37]
Chr9:138940848..140128736 [NCBI36]
Chr9:9q34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138124532)x3 copy number gain See cases [RCV000053745] Chr9:193412..138124532 [GRCh38]
Chr9:204193..141018984 [GRCh37]
Chr9:194193..140138805 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053748]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053748]|See cases [RCV000053748] Chr9:193412..138179445 [GRCh38]
Chr9:266045..141073897 [GRCh37]
Chr9:256045..140193718 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9q34.2-34.3(chr9:134174698-138138735)x3 copy number gain See cases [RCV000053814] Chr9:134174698..138138735 [GRCh38]
Chr9:137091194..141033187 [GRCh37]
Chr9:136029641..140153008 [NCBI36]
Chr9:9q34.2-34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138114463)x3 copy number gain See cases [RCV000053746] Chr9:193412..138114463 [GRCh38]
Chr9:214367..141008915 [GRCh37]
Chr9:204367..140128736 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9q33.2-34.3(chr9:121586837-138179445)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053776]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053776]|See cases [RCV000053776] Chr9:121586837..138179445 [GRCh38]
Chr9:124349116..141073897 [GRCh37]
Chr9:123388937..140193718 [NCBI36]
Chr9:9q33.2-34.3
pathogenic
NM_007327.4(GRIN1):c.2080C>T (p.Arg694Trp) single nucleotide variant not provided [RCV001764804] Chr9:137162912 [GRCh38]
Chr9:140057364 [GRCh37]
Chr9:139177185 [NCBI36]
Chr9:9q34.3
uncertain significance|not provided
NM_007327.4(GRIN1):c.1340C>T (p.Pro447Leu) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV003642871]|not provided [RCV000117167] Chr9:137161289 [GRCh38]
Chr9:140055741 [GRCh37]
Chr9:9q34.3
uncertain significance
NM_007327.4(GRIN1):c.813C>T (p.Leu271=) single nucleotide variant not provided [RCV000084691] Chr9:137156882 [GRCh38]
Chr9:140051334 [GRCh37]
Chr9:9q34.3
not provided
NM_007327.4(GRIN1):c.1325C>T (p.Thr442Met) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV001854483]|not provided [RCV000084692] Chr9:137161183 [GRCh38]
Chr9:140055635 [GRCh37]
Chr9:9q34.3
uncertain significance|not provided
NM_007327.4(GRIN1):c.1866C>A (p.Gly622=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV003528140]|not provided [RCV000084693] Chr9:137162592 [GRCh38]
Chr9:140057044 [GRCh37]
Chr9:9q34.3
likely benign|not provided
NM_007327.4(GRIN1):c.2064C>G (p.Ser688=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV002055251]|not provided [RCV000084694] Chr9:137162896 [GRCh38]
Chr9:140057348 [GRCh37]
Chr9:9q34.3
likely benign|not provided
NM_007327.4(GRIN1):c.2214C>T (p.Phe738=) single nucleotide variant Inborn genetic diseases [RCV002426649]|Intellectual disability, autosomal dominant 8 [RCV001087452]|not provided [RCV000084695] Chr9:137163211 [GRCh38]
Chr9:140057663 [GRCh37]
Chr9:9q34.3
likely benign|not provided
NM_007327.4(GRIN1):c.2445G>A (p.Gly815=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV001088061]|not provided [RCV000084696] Chr9:137163760 [GRCh38]
Chr9:140058212 [GRCh37]
Chr9:9q34.3
likely benign|not provided
NM_007327.4(GRIN1):c.2563G>A (p.Val855Ile) single nucleotide variant not provided [RCV000084697] Chr9:137163878 [GRCh38]
Chr9:140058330 [GRCh37]
Chr9:9q34.3
not provided
NM_007327.4(GRIN1):c.2637A>G (p.Thr879=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV002514509]|not provided [RCV000084698] Chr9:137165233 [GRCh38]
Chr9:140059685 [GRCh37]
Chr9:9q34.3
likely benign|not provided
NM_007327.4(GRIN1):c.1467+8G>A single nucleotide variant Inborn genetic diseases [RCV002390264]|Intellectual disability, autosomal dominant 8 [RCV001519889]|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive [RCV001701507]|not provided [RCV000711868]|not specified [RCV000117168] Chr9:137161424 [GRCh38]
Chr9:140055876 [GRCh37]
Chr9:9q34.3
benign|likely benign|conflicting interpretations of pathogenicity
NM_007327.4(GRIN1):c.2241G>C (p.Val747=) single nucleotide variant Inborn genetic diseases [RCV002312119]|Intellectual disability, autosomal dominant 8 [RCV000464613]|not provided [RCV004717962]|not specified [RCV000117169] Chr9:137163238 [GRCh38]
Chr9:140057690 [GRCh37]
Chr9:9q34.3
benign|likely benign|conflicting interpretations of pathogenicity
NM_007327.4(GRIN1):c.2244G>C (p.Thr748=) single nucleotide variant Inborn genetic diseases [RCV002312120]|Intellectual disability, autosomal dominant 8 [RCV000459405]|not provided [RCV004717963]|not specified [RCV000117170] Chr9:137163241 [GRCh38]
Chr9:140057693 [GRCh37]
Chr9:9q34.3
benign|likely benign|conflicting interpretations of pathogenicity
NM_007327.4(GRIN1):c.789A>G (p.Pro263=) single nucleotide variant Inborn genetic diseases [RCV002312121]|Intellectual disability, autosomal dominant 8 [RCV001519887]|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive [RCV001701670]|not provided [RCV000711872]|not specified [RCV000117171] Chr9:137156786 [GRCh38]
Chr9:140051238 [GRCh37]
Chr9:9q34.3
benign|likely benign|conflicting interpretations of pathogenicity
NM_007327.4(GRIN1):c.855G>A (p.Val285=) single nucleotide variant Inborn genetic diseases [RCV002312122]|Intellectual disability, autosomal dominant 8 [RCV001519888]|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive [RCV001701601]|not provided [RCV004717964]|not specified [RCV000117172] Chr9:137156924 [GRCh38]
Chr9:140051376 [GRCh37]
Chr9:9q34.3
benign|likely benign|conflicting interpretations of pathogenicity
NM_007327.4(GRIN1):c.505G>A (p.Asp169Asn) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV001313303]|not provided [RCV000255971] Chr9:137145837 [GRCh38]
Chr9:140040289 [GRCh37]
Chr9:9q34.3
uncertain significance
NM_007327.4(GRIN1):c.1331C>T (p.Pro444Leu) single nucleotide variant Inborn genetic diseases [RCV002317794]|Intellectual disability, autosomal dominant 8 [RCV001079792]|not provided [RCV000255622] Chr9:137161189 [GRCh38]
Chr9:140055641 [GRCh37]
Chr9:9q34.3
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_007327.4(GRIN1):c.1114-5C>T single nucleotide variant not specified [RCV000603124] Chr9:137158616 [GRCh38]
Chr9:140053068 [GRCh37]
Chr9:9q34.3
likely benign
NM_007327.4(GRIN1):c.2188A>C (p.Ile730Leu) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV001303478] Chr9:137163185 [GRCh38]
Chr9:140057637 [GRCh37]
Chr9:9q34.3
uncertain significance
NM_007327.4(GRIN1):c.2443G>A (p.Gly815Arg) single nucleotide variant GRIN1-related disorder [RCV004528975]|Inborn genetic diseases [RCV000190763]|Intellectual disability, autosomal dominant 8 [RCV003528151]|not provided [RCV004719740] Chr9:137163668 [GRCh38]
Chr9:140058120 [GRCh37]
Chr9:9q34.3
pathogenic
NM_007327.4(GRIN1):c.350C>T (p.Pro117Leu) single nucleotide variant Malignant tumor of prostate [RCV000149093] Chr9:137142104 [GRCh38]
Chr9:140036556 [GRCh37]
Chr9:9q34.3
uncertain significance
GRCh38/hg38 9p24.3-q34.3(chr9:204193-138179445) copy number gain See cases [RCV000133791] Chr9:204193..138179445 [GRCh38]
Chr9:204193..141073897 [GRCh37]
Chr9:194193..140193718 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
NM_007327.4(GRIN1):c.1339+15C>T single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV001332980] Chr9:137161212 [GRCh38]
Chr9:140055664 [GRCh37]
Chr9:9q34.3
uncertain significance
GRCh38/hg38 9q34.11-34.3(chr9:130513207-138124532)x3 copy number gain See cases [RCV000133778] Chr9:130513207..138124532 [GRCh38]
Chr9:133388594..141018984 [GRCh37]
Chr9:132378415..140138805 [NCBI36]
Chr9:9q34.11-34.3
pathogenic
GRCh38/hg38 9q34.11-34.3(chr9:129068560-138179445)x3 copy number gain See cases [RCV000134916] Chr9:129068560..138179445 [GRCh38]
Chr9:131830839..141073897 [GRCh37]
Chr9:130870660..140193718 [NCBI36]
Chr9:9q34.11-34.3
pathogenic
GRCh38/hg38 9q33.2-34.3(chr9:121073102-138179445)x3 copy number gain See cases [RCV000134920] Chr9:121073102..138179445 [GRCh38]
Chr9:123835380..141073897 [GRCh37]
Chr9:122875201..140193718 [NCBI36]
Chr9:9q33.2-34.3
pathogenic
GRCh38/hg38 9q34.13-34.3(chr9:132986903-138114463)x3 copy number gain See cases [RCV000136790] Chr9:132986903..138114463 [GRCh38]
Chr9:135862290..141008915 [GRCh37]
Chr9:134852111..140128736 [NCBI36]
Chr9:9q34.13-34.3
pathogenic
GRCh38/hg38 9q34.2-34.3(chr9:133504071-138159073)x3 copy number gain See cases [RCV000137825] Chr9:133504071..138159073 [GRCh38]
Chr9:136324358..141053525 [GRCh37]
Chr9:135314179..140173346 [NCBI36]
Chr9:9q34.2-34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138124524)x3 copy number gain See cases [RCV000138783] Chr9:193412..138124524 [GRCh38]
Chr9:204090..141018976 [GRCh37]
Chr9:194090..140138797 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p11.2-q34.3(chr9:193412-138159073)x3 copy number gain See cases [RCV000139207] Chr9:193412..138159073 [GRCh38]
Chr9:68420641..141053525 [GRCh37]
Chr9:67910461..140173346 [NCBI36]
Chr9:9p11.2-q34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138159073)x3 copy number gain See cases [RCV000138962] Chr9:193412..138159073 [GRCh38]
Chr9:204104..141053525 [GRCh37]
Chr9:194104..140173346 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic|conflicting data from submitters
GRCh38/hg38 9q34.2-34.3(chr9:133996227-138124524)x3 copy number gain See cases [RCV000139807] Chr9:133996227..138124524 [GRCh38]
Chr9:136861349..141018976 [GRCh37]
Chr9:135851170..140138797 [NCBI36]
Chr9:9q34.2-34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:203861-138125937)x3 copy number gain See cases [RCV000141876] Chr9:203861..138125937 [GRCh38]
Chr9:203861..141020389 [GRCh37]
Chr9:193861..140140210 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9q34.2-34.3(chr9:133918071-138159073)x3 copy number gain See cases [RCV000142955] Chr9:133918071..138159073 [GRCh38]
Chr9:136783193..141053525 [GRCh37]
Chr9:135773014..140173346 [NCBI36]
Chr9:9q34.2-34.3
pathogenic
GRCh38/hg38 9q34.3(chr9:136877772-138124524)x1 copy number loss See cases [RCV000142978] Chr9:136877772..138124524 [GRCh38]
Chr9:139772224..141018976 [GRCh37]
Chr9:138892045..140138797 [NCBI36]
Chr9:9q34.3
pathogenic
GRCh38/hg38 9q34.13-34.3(chr9:132386553-138059695)x3 copy number gain See cases [RCV000142636] Chr9:132386553..138059695 [GRCh38]
Chr9:135261940..140954147 [GRCh37]
Chr9:134251761..140073968 [NCBI36]
Chr9:9q34.13-34.3
pathogenic
GRCh38/hg38 9q34.3(chr9:137092629-137270028)x3 copy number gain See cases [RCV000142744] Chr9:137092629..137270028 [GRCh38]
Chr9:139987081..140164480 [GRCh37]
Chr9:139106902..139284301 [NCBI36]
Chr9:9q34.3
benign
GRCh38/hg38 9q34.3(chr9:135704780-138125937)x4 copy number gain See cases [RCV000143394] Chr9:135704780..138125937 [GRCh38]
Chr9:138596626..141020389 [GRCh37]
Chr9:137736447..140140210 [NCBI36]
Chr9:9q34.3
likely pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:203862-138125937)x3 copy number gain See cases [RCV000143476] Chr9:203862..138125937 [GRCh38]
Chr9:203862..141020389 [GRCh37]
Chr9:193862..140140210 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9q34.3(chr9:136323974-138014606)x1 copy number loss See cases [RCV000148284] Chr9:136323974..138014606 [GRCh38]
Chr9:139218428..140909058 [GRCh37]
Chr9:138338249..140028879 [NCBI36]
Chr9:9q34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 copy number gain See cases [RCV000148113] Chr9:193412..138179445 [GRCh38]
Chr9:204193..141073897 [GRCh37]
Chr9:194193..140193718 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
NM_007327.4(GRIN1):c.1005T>C (p.Thr335=) single nucleotide variant Inborn genetic diseases [RCV002317686]|Intellectual disability, autosomal dominant 8 [RCV001089362]|not provided [RCV000540707]|not specified [RCV000192317] Chr9:137158415 [GRCh38]
Chr9:140052867 [GRCh37]
Chr9:9q34.3
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_007327.4(GRIN1):c.357G>A (p.Leu119=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV002517077]|not provided [RCV000840921]|not specified [RCV000193451] Chr9:137142111 [GRCh38]
Chr9:140036563 [GRCh37]
Chr9:9q34.3
likely benign|uncertain significance
NM_007327.4(GRIN1):c.768G>C (p.Gly256=) single nucleotide variant Inborn genetic diseases [RCV002317687]|Intellectual disability, autosomal dominant 8 [RCV001079498]|not provided [RCV000458354]|not specified [RCV000194689] Chr9:137156765 [GRCh38]
Chr9:140051217 [GRCh37]
Chr9:9q34.3
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_007327.4(GRIN1):c.2499C>T (p.Ile833=) single nucleotide variant Inborn genetic diseases [RCV002426923]|Intellectual disability, autosomal dominant 8 [RCV000649668]|not provided [RCV001697233]|not specified [RCV000194742] Chr9:137163814 [GRCh38]
Chr9:140058266 [GRCh37]
Chr9:9q34.3
likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_007327.4(GRIN1):c.1858G>C (p.Gly620Arg) single nucleotide variant Inborn genetic diseases [RCV000622498]|Intellectual disability, autosomal dominant 8 [RCV000191091]|Seizure [RCV001526577]|not provided [RCV000479068] Chr9:137162510 [GRCh38]
Chr9:140056962 [GRCh37]
Chr9:9q34.3
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity
NM_007327.4(GRIN1):c.255C>T (p.Ser85=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV001406456]|not specified [RCV000192623] Chr9:137139741 [GRCh38]
Chr9:140034193 [GRCh37]
Chr9:9q34.3
likely benign|uncertain significance
NM_007327.4(GRIN1):c.1437G>A (p.Val479=) single nucleotide variant not specified [RCV000193519] Chr9:137161386 [GRCh38]
Chr9:140055838 [GRCh37]
Chr9:9q34.3
uncertain significance
NM_007327.4(GRIN1):c.237C>T (p.Cys79=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000543147]|not specified [RCV000605384] Chr9:137139723 [GRCh38]
Chr9:140034175 [GRCh37]
Chr9:9q34.3
benign|likely benign|uncertain significance
NM_007327.4(GRIN1):c.2488C>T (p.Leu830=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000544512] Chr9:137163803 [GRCh38]
Chr9:140058255 [GRCh37]
Chr9:9q34.3
likely benign
NM_007327.4(GRIN1):c.679G>C (p.Asp227His) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000210389]|Intellectual disability, autosomal dominant 8 [RCV000760222]|NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS WITH OR WITHOUT SEIZURES, AUTOSOMAL RECESSIVE [RCV002051695] Chr9:137156676 [GRCh38]
Chr9:140051128 [GRCh37]
Chr9:9q34.3
pathogenic|likely pathogenic
NM_007327.4(GRIN1):c.1670C>G (p.Pro557Arg) single nucleotide variant Intellectual disability [RCV000224047]|not provided [RCV003229823] Chr9:137162209 [GRCh38]
Chr9:140056661 [GRCh37]
Chr9:9q34.3
pathogenic
NM_007327.4(GRIN1):c.525G>A (p.Ala175=) single nucleotide variant Inborn genetic diseases [RCV002313944]|Intellectual disability, autosomal dominant 8 [RCV000232465]|not provided [RCV003437028]|not specified [RCV000616760] Chr9:137145857 [GRCh38]
Chr9:140040309 [GRCh37]
Chr9:9q34.3
benign|likely benign
NM_007327.4(GRIN1):c.2333+9C>A single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000234646]|not specified [RCV000431873] Chr9:137163339 [GRCh38]
Chr9:140057791 [GRCh37]
Chr9:9q34.3
benign|likely benign|uncertain significance
NM_007327.4(GRIN1):c.246C>T (p.Leu82=) single nucleotide variant Inborn genetic diseases [RCV002429125]|Intellectual disability, autosomal dominant 8 [RCV000228541] Chr9:137139732 [GRCh38]
Chr9:140034184 [GRCh37]
Chr9:9q34.3
benign|likely benign
GRCh37/hg19 9p24.3-q34.3(chr9:163131-141122114)x3 copy number gain See cases [RCV000240081] Chr9:163131..141122114 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
NM_007327.4(GRIN1):c.570+16G>A single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV002531692]|not specified [RCV000600918] Chr9:137145918 [GRCh38]
Chr9:140040370 [GRCh37]
Chr9:9q34.3
likely benign
NM_007327.4(GRIN1):c.1643G>A (p.Arg548Gln) single nucleotide variant Inborn genetic diseases [RCV000622458]|Intellectual disability, autosomal dominant 8 [RCV002051870]|not provided [RCV001591400] Chr9:137162182 [GRCh38]
Chr9:140056634 [GRCh37]
Chr9:9q34.3
pathogenic|conflicting interpretations of pathogenicity
NM_007327.4(GRIN1):c.297C>T (p.Asn99=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV002532748]|not provided [RCV001718946] Chr9:137142051 [GRCh38]
Chr9:140036503 [GRCh37]
Chr9:9q34.3
likely benign
NM_007327.4(GRIN1):c.759G>A (p.Glu253=) single nucleotide variant not provided [RCV000487625] Chr9:137156756 [GRCh38]
Chr9:140051208 [GRCh37]
Chr9:9q34.3
uncertain significance
NM_007327.4(GRIN1):c.947A>G (p.Lys316Arg) single nucleotide variant not provided [RCV000521029] Chr9:137157016 [GRCh38]
Chr9:140051468 [GRCh37]
Chr9:9q34.3
uncertain significance
NM_007327.4(GRIN1):c.1114-8A>G single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000553061] Chr9:137158613 [GRCh38]
Chr9:140053065 [GRCh37]
Chr9:9q34.3
likely benign
NM_007327.4(GRIN1):c.1888C>T (p.Arg630Cys) single nucleotide variant not provided [RCV002285989] Chr9:137162614 [GRCh38]
Chr9:140057066 [GRCh37]
Chr9:9q34.3
uncertain significance
NM_007327.4(GRIN1):c.996T>A (p.Asp332Glu) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV003642972]|not provided [RCV001760749] Chr9:137158406 [GRCh38]
Chr9:140052858 [GRCh37]
Chr9:9q34.3
uncertain significance
NM_007327.4(GRIN1):c.1853G>T (p.Gly618Val) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV001268942] Chr9:137162505 [GRCh38]
Chr9:140056957 [GRCh37]
Chr9:9q34.3
pathogenic
NM_007327.4(GRIN1):c.1975C>T (p.Arg659Trp) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV002526005]|not provided [RCV000488193] Chr9:137162701 [GRCh38]
Chr9:140057153 [GRCh37]
Chr9:9q34.3
pathogenic|uncertain significance
NM_007327.4(GRIN1):c.705C>T (p.Ala235=) single nucleotide variant GRIN1-related disorder [RCV004535541]|Inborn genetic diseases [RCV002318591]|Intellectual disability, autosomal dominant 8 [RCV001081647]|not provided [RCV000488242] Chr9:137156702 [GRCh38]
Chr9:140051154 [GRCh37]
Chr9:9q34.3
likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_007327.4(GRIN1):c.1237C>T (p.Pro413Ser) single nucleotide variant not provided [RCV002288026] Chr9:137161095 [GRCh38]
Chr9:140055547 [GRCh37]
Chr9:9q34.3
uncertain significance
NM_007327.4(GRIN1):c.1198-2del deletion Intellectual disability, autosomal dominant 8 [RCV000529179] Chr9:137161054 [GRCh38]
Chr9:140055506 [GRCh37]
Chr9:9q34.3
likely pathogenic|uncertain significance
NM_007327.4(GRIN1):c.387G>A (p.Ser129=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV001050499]|not provided [RCV000605049] Chr9:137142141 [GRCh38]
Chr9:140036593 [GRCh37]
Chr9:9q34.3
likely benign|uncertain significance
NM_007327.4(GRIN1):c.2417C>A (p.Ala806Glu) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000625828] Chr9:137163642 [GRCh38]
Chr9:140058094 [GRCh37]
Chr9:9q34.3
likely pathogenic
NM_007327.4(GRIN1):c.63G>A (p.Ala21=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000649664]|not specified [RCV000606276] Chr9:137139549 [GRCh38]
Chr9:140034001 [GRCh37]
Chr9:9q34.3
likely benign
NM_007327.4(GRIN1):c.2420C>T (p.Thr807Ile) single nucleotide variant Inborn genetic diseases [RCV000622627]|Intellectual disability, autosomal dominant 8 [RCV001868141] Chr9:137163645 [GRCh38]
Chr9:140058097 [GRCh37]
Chr9:9q34.3
likely pathogenic|uncertain significance
NM_007327.4(GRIN1):c.-16C>T single nucleotide variant not specified [RCV000600931] Chr9:137139471 [GRCh38]
Chr9:140033923 [GRCh37]
Chr9:9q34.3
likely benign
NM_007327.4(GRIN1):c.957G>A (p.Pro319=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000767988]|Intellectual disability, autosomal dominant 8 [RCV003224407] Chr9:137157026 [GRCh38]
Chr9:140051478 [GRCh37]
Chr9:9q34.3
conflicting interpretations of pathogenicity|uncertain significance
NM_007327.4(GRIN1):c.1645A>C (p.Ser549Arg) single nucleotide variant Inborn genetic diseases [RCV000624738]|Intellectual disability, autosomal dominant 8 [RCV003152721] Chr9:137162184 [GRCh38]
Chr9:140056636 [GRCh37]
Chr9:9q34.3
pathogenic|likely pathogenic
NM_007327.4(GRIN1):c.1656C>G (p.Asp552Glu) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000576882] Chr9:137162195 [GRCh38]
Chr9:140056647 [GRCh37]
Chr9:9q34.3
pathogenic
NM_007327.4(GRIN1):c.649C>T (p.Arg217Trp) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV001859995]|NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS WITH OR WITHOUT SEIZURES, AUTOSOMAL RECESSIVE [RCV002051707] Chr9:137149087 [GRCh38]
Chr9:140043539 [GRCh37]
Chr9:9q34.3
pathogenic|uncertain significance
NM_007327.4(GRIN1):c.2479G>A (p.Gly827Arg) AND NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000576881]|NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS AND WITH OR WITHOUT SEIZURES, AUTOSOMAL DOMINANT [RCV002051706]|Neurodevelopmental disorder [RCV001375029]|not provided [RCV001092464] Chr9:137163794 [GRCh38]
Chr9:140058246 [GRCh37]
Chr9:9q34.3
pathogenic|uncertain significance
NM_007327.4(GRIN1):c.1656C>A (p.Asp552Glu) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000576888] Chr9:137162195 [GRCh38]
Chr9:140056647 [GRCh37]
Chr9:9q34.3
pathogenic
NM_007327.4(GRIN1):c.879_880insCTCGAT (p.His293_Glu294insLeuAsp) insertion not provided [RCV000598843] Chr9:137156948..137156949 [GRCh38]
Chr9:140051400..140051401 [GRCh37]
Chr9:9q34.3
uncertain significance
NM_007327.4(GRIN1):c.2530C>T (p.Arg844Cys) single nucleotide variant Inborn genetic diseases [RCV000623606]|Intellectual disability [RCV001260636]|Intellectual disability, autosomal dominant 8 [RCV000763192]|Intellectual disability, autosomal dominant 8 [RCV001043920]|not provided [RCV000730546] Chr9:137163845 [GRCh38]
Chr9:140058297 [GRCh37]
Chr9:9q34.3
pathogenic|likely pathogenic
NM_007327.4(GRIN1):c.2531G>T (p.Arg844Leu) single nucleotide variant Global developmental delay [RCV000735322]|Intellectual disability, autosomal dominant 8 [RCV001239704]|See cases [RCV003156119] Chr9:137163846 [GRCh38]
Chr9:140058298 [GRCh37]
Chr9:9q34.3
pathogenic|likely pathogenic|uncertain significance
NM_007327.4(GRIN1):c.734A>T (p.Tyr245Phe) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000767986]|Intellectual disability, autosomal dominant 8 [RCV003224406]|not provided [RCV002284436] Chr9:137156731 [GRCh38]
Chr9:140051183 [GRCh37]
Chr9:9q34.3
uncertain significance
NM_007327.4(GRIN1):c.780C>T (p.Arg260=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV001081754]|not provided [RCV000416174] Chr9:137156777 [GRCh38]
Chr9:140051229 [GRCh37]
Chr9:9q34.3
likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_007327.4(GRIN1):c.351C>G (p.Pro117=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV000538028] Chr9:137142105 [GRCh38]
Chr9:140036557 [GRCh37]
Chr9:9q34.3
likely benign
NM_007327.4(GRIN1):c.1670C>T (p.Pro557Leu) single nucleotide variant not provided [RCV000412873] Chr9:137162209 [GRCh38]
Chr9:140056661 [GRCh37]
Chr9:9q34.3
likely pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:62525-141006407) copy number gain See cases [RCV000449375] Chr9:62525..141006407 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
NM_007327.4(GRIN1):c.1854_1859dup (p.Ile619_Gly620dup) duplication Intellectual disability, autosomal dominant 8 [RCV000449545] Chr9:137162502..137162503 [GRCh38]
Chr9:140056954..140056955 [GRCh37]
Chr9:9q34.3
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:203861-141020389)x3 copy number gain not specified [RCV003986800] Chr9:203861..141020389 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9q33.3-34.3(chr9:128652785-141044751)x3 copy number gain See cases [RCV000447080] Chr9:128652785..141044751 [GRCh37]
Chr9:9q33.3-34.3
pathogenic
GRCh37/hg19 9q34.3(chr9:138222049-141018925)x1 copy number loss See cases [RCV000446074] Chr9:138222049..141018925 [GRCh37]
Chr9:9q34.3
pathogenic
GRCh37/hg19 9q34.3(chr9:140043049-141020389)x1 copy number loss See cases [RCV000446191] Chr9:140043049..141020389 [GRCh37]
Chr9:9q34.3
pathogenic
NM_007327.4(GRIN1):c.1198-7C>T single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV001522763]|not provided [RCV000427214] Chr9:137161049 [GRCh38]
Chr9:140055501 [GRCh37]
Chr9:9q34.3
benign|likely benign
NM_007327.4(GRIN1):c.1864+17C>T single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV002060073]|not provided [RCV001696779] Chr9:137162533 [GRCh38]
Chr9:140056985 [GRCh37]
Chr9:9q34.3
benign|likely benign
NM_007327.4(GRIN1):c.394-19G>A single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV002059719]|not specified [RCV000430913] Chr9:137145707 [GRCh38]
Chr9:140040159 [GRCh37]
Chr9:9q34.3
benign|likely benign
NM_007327.4(GRIN1):c.2008C>A (p.Pro670Thr) single nucleotide variant not provided [RCV000442420] Chr9:137162734 [GRCh38]
Chr9:140057186 [GRCh37]
Chr9:9q34.3
likely pathogenic
NM_007327.4(GRIN1):c.630G>A (p.Glu210=) single nucleotide variant Inborn genetic diseases [RCV002356592]|Intellectual disability, autosomal dominant 8 [RCV001478074]|not specified [RCV000423939] Chr9:137149068 [GRCh38]
Chr9:140043520 [GRCh37]
Chr9:9q34.3
likely benign
NM_007327.4(GRIN1):c.2444-14G>A single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV001764357]|not provided [RCV003237844]|not specified [RCV000427368] Chr9:137163745 [GRCh38]
Chr9:140058197 [GRCh37]
Chr9:9q34.3
likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_007327.4(GRIN1):c.2022C>T (p.Asn674=) single nucleotide variant not specified [RCV000431266] Chr9:137162854 [GRCh38]
Chr9:140057306 [GRCh37]
Chr9:9q34.3
likely benign
NM_007327.4(GRIN1):c.2334-18A>T single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV002062789]|not specified [RCV000434551] Chr9:137163541 [GRCh38]
Chr9:140057993 [GRCh37]
Chr9:9q34.3
likely benign
NM_007327.4(GRIN1):c.394-13C>T single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV002062660]|not specified [RCV000417934] Chr9:137145713 [GRCh38]
Chr9:140040165 [GRCh37]
Chr9:9q34.3
likely benign
NM_007327.4(GRIN1):c.696C>T (p.Tyr232=) single nucleotide variant Inborn genetic diseases [RCV002365567]|Intellectual disability, autosomal dominant 8 [RCV000649662]|not provided [RCV001698399] Chr9:137156693 [GRCh38]
Chr9:140051145 [GRCh37]
Chr9:9q34.3
likely benign
NM_007327.4(GRIN1):c.1497T>C (p.Asn499=) single nucleotide variant Intellectual disability, autosomal dominant 8 [RCV002063456]|not specified [RCV000420935] Chr9:137161953 [GRCh38]
Chr9:140056405 [GRCh37]
Chr9:9q34.3
likely benign